摘要 |
<p>The present application relates to compounds of formula (I) wherein the definitions are as described in claim 1. It has been found that the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).</p> |
申请人 |
F. HOFFMANN-LA ROCHE AG;KNUST, HENNER;LIMBERG, ANJA;NETTEKOVEN, MATTHIAS;RATNI, HASANE;RIEMER, CLAUS;VIFIAN, WALTER |
发明人 |
KNUST, HENNER;LIMBERG, ANJA;NETTEKOVEN, MATTHIAS;RATNI, HASANE;RIEMER, CLAUS;VIFIAN, WALTER |